CURRUS BIOLOGICS ANNOUNCES FDA IND CLEARANCE FOR PHASE 1 TRIAL OF CUR-001 IN MESOTHELIN-POSITIVE ADVANCED REFRACTORY SOLID TUMOURS

Reuters · 1d ago

Please log in to view news